JEANINE JONES DONALD: Open Payments
NPI 1336687748 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 31 payments from 12 companies in 2025. Trend: 2023 $39 · 2024 $136 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $211 |
| Otsuka America Pharmaceutical, Inc. | 4 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| Alkermes, Inc. | 2 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Lundbeck LLC | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Bausch Health US, LLC | 2 | $33 |
| Almatica Pharma LLC | 1 | $27 |
Products named: REXULTI, Auvelity, CAPLYTA, LYBALVI, INGREZZA, COBENFY, Jornay PM, APLENZIN.
Industry payments across FL — which companies pay providers there.
